Anthony A. Fields

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.

A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Journal: Investigational new drugs
Published: March 09, 2018

Primary Tumor Location and Survival in the General Population With Metastatic Colorectal Cancer.

Primary Tumor Location and Survival in the General Population With Metastatic Colorectal Cancer.

Journal: Clinical colorectal cancer
Published: June 23, 2017

Engaging specialist oncologists in the assessment of oncology drugs in Canada.

Engaging specialist oncologists in the assessment of oncology drugs in Canada.

Journal: The Lancet. Oncology
Published: March 24, 2017

Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?

Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?

Journal: ESMO open
Published: November 04, 2016

Innovation in Healthcare Delivery: Commentary on an Evolutionary Approach.

Innovation in Healthcare Delivery: Commentary on an Evolutionary Approach.

Journal: HealthcarePapers
Published: February 09, 2016

Surgical Management of the Primary Tumor in Stage IV Colorectal Cancer: A Confirmatory Retrospective Cohort Study.

Surgical Management of the Primary Tumor in Stage IV Colorectal Cancer: A Confirmatory Retrospective Cohort Study.

Journal: Journal of Cancer
Published: December 16, 2015

Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.

Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.

Journal: Annals of surgical oncology
Published: November 09, 2015

Does it Matter Whether Canada's Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Does it Matter Whether Canada's Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Journal: PharmacoEconomics
Published: May 06, 2015

Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.

Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.

Journal: Clinical colorectal cancer
Published: March 15, 2015

Predictive Factors of the Use of Systemic Therapy in Stage IV Colorectal Cancer: Who Gets Chemotherapy?

Predictive Factors of the Use of Systemic Therapy in Stage IV Colorectal Cancer: Who Gets Chemotherapy?

Journal: Oncology
Published: May 14, 2014

Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.

Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.

Journal: Cancer
Published: August 19, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026